CTRI/2019/02/017768进行中（未招募）2 期
An Open Label Randomized Clinical Study to evaluate the efficacy of Patrapinda Swedana and Erandamooladi Basti followed by Shamana with and without Virechana in the management of Kati-Prishtha-Trik Graha with special reference to Ankylosing Spondylitis. - ASP
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients fulfilling the Assessment of Spondylo Arthritis International Society (ASAS) criteria for Ankylosing Spondylitis, or pre-diagnosed cases.
- •Patient having symptoms of Kati-Prishtha-Trik Graha, Patient having sign and symptoms of Ankylosing spondylitis, Chronicity: less than 10 yearsPatients indicated for Patrapinda Swedana, Virechana and Basti Karma.
排除标准
- •Patients having serious Cardiac, Renal or Hepatic diseases, uncontrolled Hypertension, Diabetes. Pregnant & lactating women.
- •Patients contraindicated for Patrapinda Swedana, Virechana and Basti Karma.
研究者
相似试验
已完成
4 期
A clinical study to evaluate the efficacy and safety of Proseventy in dialysis patients.CTRI/2012/03/002516Panacea Biotec Ltd180
已完成
2 期
Management of Hypothyroidism through AyurvedaCTRI/2019/02/017841ational institute of Ayurveda Jaipur90
尚未招募
2 期
A Clinical study to evaluate the efficacy and safety of Quista-DN health drink in diabetic individualsCTRI/2019/07/020179The Himalaya Drug Company
招募中
3 期
A clinical trial to study the effect of Shunthyadam Vati to prevent heart disease.CTRI/2021/01/030275Dr Abhijit Dinkarrao Shekhar
已完成
2 期
A clinical study to see the effects and safety of PNB-001 in patients with moderate COVID-19 infectioCTRI/2020/10/028423PNB Vesper Life Science Pvt Ltd40